Atai Life Sciences N.V.

NASDAQ: ATAI · Real-Time Price · USD
3.88
-0.13 (-3.24%)
At close: Aug 15, 2025, 3:59 PM
3.88
-0.13%
After-hours: Aug 15, 2025, 07:51 PM EDT

Atai Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.55M -5K 40K 273K n/a 18K 87K 172K 37K 38K 24K 170K n/a 230K 266K n/a 19.88M
Cost of Revenue
n/a 165K n/a 82K 83K 101K 74K 195K 167K 53K 36K 19K 60K 29K n/a 19K n/a
Gross Profit
1.55M -148K 40K 191K -83K -83K 13K -23K -130K -15K -12K 151K -60K 201K 266K -19K 19.88M
Operating Income
-20.37M -30.27M -22.6M -25.73M -23.98M -33.56M -26.83M -31.86M -32.53M -37.56M -38.42M -35.36M -33.44M -45.17M -33.36M -61.32M 4.05M
Interest Income
186K 193K 160K 118K 307K 656K 612K 303K 275K 187K 145K 117K 98K 125K 8K 35K 37K
Pretax Income
-26.31M -39.18M -26.46M -57.35M -25.68M -18.32M 43.85M -31.66M -33.16M -39.32M -33.13M -30.81M -31.92M -48.58M -26.47M -67.3M 5.75M
Net Income
-26.43M -38.96M -26.29M -57.31M -26.71M -18.29M 44.24M -33.04M -33.32M -45.32M -33.27M -30.86M -31.96M -88.88M -31.16M -48.46M 688K
Selling & General & Admin
10.6M 11.32M 10.27M 13.4M 12.46M 19.42M 13.63M 16.56M 13.97M 15.73M 19.42M 17.22M 17.98M 25.88M 20.26M 37.33M 9.27M
Research & Development
11.33M 18.94M 12.38M 12.61M 11.45M 14.05M 13.29M 15.48M 19.28M 21.88M 19.03M 17.95M 15.46M 19.53M 13.36M 16.03M 5.58M
Other Expenses
n/a 5K n/a n/a -5K -111K n/a 204K 58K n/a -100K -12K n/a n/a -29K n/a n/a
Operating Expenses
21.93M 30.26M 22.64M 26M 23.9M 33.48M 26.92M 32.03M 33.25M 37.6M 38.45M 35.17M 33.44M 45.41M 33.63M 53.36M 14.86M
Interest Expense
900K 952K 783K 702K 687K 691K 686K 658K 622K n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
21.93M 30.26M 22.64M 26M 23.98M 33.58M 26.92M 32.03M 33.25M 37.6M 38.45M 35.17M 33.44M 45.41M 33.63M 53.36M 14.86M
Income Tax Expense
156K -193K -178K 19K -4K 428K 238K 185K 165K 6M 135K 51K 41K -4.42M 368K 58K 6K
Shares Outstanding (Basic)
176.27M 160.16M 160.62M 160.39M 158.89M 158.84M 155.79M 155.79M 155.79M 158.7M 154.03M 153.97M 153.53M 150.06M 148.37M 132.27M 151.86M
Shares Outstanding (Diluted)
176.27M 160.16M 160.62M 160.39M 158.89M 158.84M 155.79M 155.79M 155.79M 158.7M 156.61M 153.97M 153.53M 151.13M 151.13M 132.27M 151.86M
EPS (Basic)
-0.15 -0.24 -0.16 -0.36 -0.17 -0.12 0.28 -0.21 -0.21 -0.29 -0.22 -0.2 -0.21 -0.59 -0.21 -0.37 0.00
EPS (Diluted)
-0.15 -0.24 -0.16 -0.36 -0.17 -0.12 0.28 -0.21 -0.21 -0.29 -0.21 -0.2 -0.21 -0.59 -0.21 -0.37 0.00
EBITDA
-25.04M -38.01M -25.6M -56.67M -24.91M -17.53M -26.76M -30.8M -32.37M -37.51M -33.1M -30.79M -31.86M -38.6M -33.36M -53.34M 5.03M
EBIT
-25.41M -38.23M -25.68M -56.76M -24.99M -17.63M 44.53M -31M -32.53M -37.56M -33.13M -30.81M -31.92M -38.63M -33.36M -53.36M 5.02M
Depreciation & Amortization
365K 225K 83K 82K 83K 101K 74K 195K 167K 53K 36K 19K 60K 29K -7K 19K 6K